The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barre syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency’s website showed on Thursday. Medicines and Healthcare products Regulatory Agency’s (MHRA) decision comes after the European medicines agency added GBS as a …
Read More »